Lyric proudly announces its recognition as Best in KLAS 2025 for Pre-Payment Accuracy & Integrity Solutions. This award highlights Lyric’s innovative technology platform and strategic partnerships, delivering unmatched value and customer trust in the healthcare industry. Learn more about our journey to excellence.

Lyric announced it would offer coordination of benefits solutions as part of its leading payment integrity offering. The first component of Lyric’s overall COB offering is available as a result of a strategic partnership with Strout (formerly the Strout Company), a market leader in Medicare COB.

Lyric to offer its newest innovation, 42, enabling customers to unlock greater value, reduce administrative costs, and simplify technology deployment related to payment accuracy and healthcare affordability.

The Diagnostics Module—available through Lyric’s expanded partnership with Concert—will seamlessly deliver Concert’s integrated policy and payment accuracy capabilities for a growing scope of laboratory testing.

Lyric COB offering made possible through strategic partnership with Strout and customized connections built by DatumSure

Lyric, a leader in technology-first payment accuracy solutions, today announced that Ravi Umarji has joined as Chief Financial Officer.

Lyric to offer Codoxo’s innovative solutions to customers via the LyricIQ ecosystem enabling simple integration and quicker speed to value

Lyric is proud to announce recognition by KLAS Research in the inaugural KLAS Payment Accuracy & Integrity Solutions 2023 Report.

Lyric, an AI-first healthcare technology company, and Autonomize AI, an emerging leader in Generative AI solutions, have announced a strategic partnership designed to enhance healthcare efficiency and transparency. This alliance will bring Autonomize AI's secure, trusted generative AI technology to Lyric’s extensive network of customers.

Lyric, an industry leader in payment accuracy, today announced that Akshay Sharma, Vijay Murugappan, and Yevgeny “Gene” German have joined the company as Chief AI Officer, Chief Commercial Officer, and Chief Product & Technology Officer, respectively.

Lyric, an industry leader in payment accuracy, today unveiled its groundbreaking Artificial Intelligence as a Service (AIaaS) solution, LyriclQ.

Lyric, formerly ClaimsXten Portfolio, has partnered with Concert Genetics (Concert), a leader in end-to-end genetic testing management, to deliver solutions to health plan payers who seek to maximize payment accuracy for genetic testing claims.

Lyric, a leading claims editing software business owned by TPG Capital, today announced the appointment of Raj Ronanki as Chief Executive Officer. Ronanki most recently served as Senior Vice President of Elevance Health and President of Carelon Digital Platforms.